UNSPSC 51263122: Esmolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H25NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MDY902UXSR, chemically known as benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, methyl ester but generally known as esmolol, which bears US NIH Compound Identifier 59768. European Medicines Agency schedules Esmolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13718MIG.

UNSPSC 51263122 Esmolol, a Commodity-tier code, does not align with the recent state and local procurement activity tagged under it. The single posted opportunity from Seminole County, Florida solicits naloxone and drug deactivation systems—pharmaceutical products and safety equipment outside the scope of esmolol, a beta-blocker medication used in acute care settings. State and local governments do purchase pharmaceuticals through procurement processes, but the recent record under this code shows no activity directly relevant to esmolol procurement.

Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The due date listed in the summary metadata (July 26, 2023) appears to be a data-entry error given the June 2026 posting date. Vendors must include shipping and delivery costs, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation and commercial general liability insurance. The contract carries a two-year initial term with an optional one-year renewal and a three-month probationary period. The mismatch between the code's nominal scope and the opportunity's actual content suggests either a tagging error in the state and local procurement system or that this code is used inconsistently across jurisdictions. The code shows no recent relevant activity for esmolol-specific procurement.